Get the latest Terumo Aortic news featuring our tailored thoracic,
thoracoabdominal and abdominal devices.

Terumo Aortic Announces US FDA Breakthrough Device designation for Thoraflex Hybrid device

Terumo Aortic today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its innovative Thoraflex Hybrid stented device for complex aortic arch repair.

Terumo Donates USD 2.4 Million in Cash and Products to Support COVID-19 Pandemic Relief Efforts Worldwide

Contributions include USD 1 million to the COVID-19 Solidarity Response Fund for WHO

Terumo acquires Aortica Corporation

Terumo Acquires Aortica Corporation to Support Continued Growth of Its Vascular Graft Business and Contribute to Personalised Aortic Therapy

For more updates on Terumo Aortic, follow us on Twitter or LinkedIn.


Please reach out to our media relations contact for
press enquiries about our innovative solutions.

Carrie White
Head, Global Marketing Communications
+44 (0) 141 812 5555